How Disruptive is RAP?, page-8

Its all about execution here on in for ResApp.

How efficient will ResApp be in concluding trials, submitting paperwork, signing deals post FDA approvals etc. The Adult US Study will be a lot easier knowing that revenues are imminent and knowing how positive the pediatric trials are.

If you take ResApps first timeline to commercialisation, there has been almost a year in delays. But what is a year or two delay if the prize is so great.

The market is happy to wait and see and so am I.